Sirolimus
- Product NDC
- 70518-3547
- 11-digit product format
- 705183547
- Labeler code
- 70518
- Product ID
- 70518-3547_e9e9fe8d-e795-a14e-e053-2a95a90af132
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Sirolimus
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA214753
- Marketing category
- ANDA
- Marketing start
- 2022-09-30
- Marketing end
- 0000-00-00
- Substance
- SIROLIMUS
- Active strength
- 1 mg/1
- Pharmacologic classes
- Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-3547-0 | 70518354700 | 100 POUCH in 1 BOX (70518-3547-0) > 1 TABLET in 1 POUCH (70518-3547-1) | 100 pouch | 2022-09-30 | 0000-00-00 | No | No | Current |